Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315106 · ClinicalTrials.gov registry record
High Resolution 3D Diffusion-weighted Breast MRI
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 50
- Enrollment target
NCT01315106: Clinical Trial study, sponsored by Stanford University.
NCT01315106 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01315106 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how well a new MRI technique called "High resolution 3D diffusion-weighted breast MRI" detects breast cancer.
Interventions
- DEVICE Magnetic Resonance Image Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-01-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01315106
The ClinicalTrials.gov registry entry for NCT01315106 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Image Scanner is the first listed.
NCT01315106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01315106 about?
NCT01315106 is a clinical study titled "High Resolution 3D Diffusion-weighted Breast MRI". The purpose of this study is to determine how well a new MRI technique called "High resolution 3D diffusion-weighted breast MRI" detects breast cancer.
What is the current status of trial NCT01315106?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2011-03. Estimated completion is 2014-01-07.
What interventions are being tested in trial NCT01315106?
The interventions under investigation include: Magnetic Resonance Image Scanner (DEVICE).
Who is sponsoring clinical trial NCT01315106?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.